Results 241 to 250 of about 286,275 (354)
The impact of accumulating immune adaptation in circulating strains of HIV‐1
Abstract Background Mutations in human immunodeficiency virus type 1 (HIV‐1) enable the virus to evade recognition and killing by human leucocyte antigen (HLA)‐restricted T cells. These viral adaptations are specific to the HLA type of individuals and are therefore evident as HLA allele‐HIV sequence associations at the population level. Most studies of
Marwah Al‐kaabi +7 more
wiley +1 more source
Prodrug strategies in developing antiviral nucleoside analogs. [PDF]
Suresh RR +15 more
europepmc +1 more source
Abstract Objectives To characterize real‐world treatment switching in France to bictegravir (BIC or B) or dolutegravir (DTG)‐based regimens with a focus on treatment persistence, effectiveness (HIV‐1 RNA ≤50 copies/ml) and particular attention to the prevalence and incidence of comorbidities. Methods People living with HIV from the prospective ANRS‐CO3‐
O. Leleux +15 more
wiley +1 more source
Nucleoside Analogue with Thymidine Nucleobase Inhibits <i>Leishmania infantum</i> and Depolarizes the Plasma Membrane Potential In Vitro. [PDF]
Menezes C +5 more
europepmc +1 more source
Abstract Objectives Low‐level viremia (LLV) has been associated with an increased risk of virological failure among adults on antiretroviral therapy (ART). However, evidence on the clinical implications of LLV among adolescents living with HIV remains limited.
Zea Leon +7 more
wiley +1 more source
Genetic diversity and drug resistance mutations of HIV-1 in Ghana: a systematic review of two decades. [PDF]
Appiah P +12 more
europepmc +1 more source
PYRIMIDINE NUCLEOSIDE ANTAGONISTS
T K, FUKUHARA, D W, VISSER
openaire +2 more sources
Abstract Objectives Aging people with HIV are increasingly affected by multimorbidity and polypharmacy, which heighten the risk of drug–drug interactions (DDIs) and potentially inappropriate medications (PIMs). This study evaluated a multidisciplinary, AI‐supported quality improvement intervention designed to optimize polypharmacy management in older ...
Jovana Milic +13 more
wiley +1 more source

